CORDIS
EU research results

CORDIS

English EN
European cell therapy in the nervous system

European cell therapy in the nervous system

Objective

Ectins will find commercially viable ways to derive conditionally immortalised neural stem cells, identify their key phenotype features, patterns of gene expression and biological activities that predict in vivo efficacy. We shall demonstrate clinical potential, study dosing and cell placement through developing predictive animal models of human neurological disease states. Media formulations will be optimised for long term viability, maintain efficacious properties and minimise toxicity. We shall develop non-invasive magnetic resonance imaging methods to follow the activity of grafted cells in human stroke patients. Scientific innovation at all stages of the programme will ensure future product pipelines.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

RENEURON LIMITED

Address

5-11 Lavington Street
Se1 0nz London

United Kingdom

Administrative Contact

Ian MISCAMPBELL (Mr.)

Participants (8)

Sort alphabetically

Expand all

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

Italy

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

KING'S COLLEGE LONDON

United Kingdom

LUDWIG INSTITUTE FOR CANCER RESEARCH

United Kingdom

MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.

Germany

MEDI-CULT A/S

Denmark

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

United Kingdom

UNIVERSITY OF HELSINKI

Finland

Project information

Grant agreement ID: QLK3-CT-1999-00894

  • Start date

    1 March 2000

  • End date

    31 August 2003

Funded under:

FP5-LIFE QUALITY

  • Overall budget:

    € 6 934 222

  • EU contribution

    € 4 217 976

Coordinated by:

RENEURON LIMITED

United Kingdom